SHANDONG BOAN BIOTECH.H 1 Cash Flow Reinvestment Rate

Latest as of December 2025: 4.22x

SHANDONG BOAN BIOTECH.H 1 cash flow reinvestment rate. SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Cash Flow Reinvestment Rate of 4.22x as of December 2025, reinvesting €274.05 Million (capex €274.05 Million ) from operating cash flow of €64.89 Million. Explore cash flow to debt ratio of SHANDONG BOAN BIOTECH.H 1 to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

4.22x
(Capex + Investments) / Operating CF

Total Reinvested

€274.05 Million
Capex + Investments

Operating Cash Flow

€64.89 Million
EUR

Capital Expenditures

€274.05 Million
EUR

Cash Flow Reinvestment Rate of SHANDONG BOAN BIOTECH.H 1 (2025–2025)

Cash flow reinvestment rate of SHANDONG BOAN BIOTECH.H 1 from 2025 to 2025. Historical reinvestment intensity for SHANDONG BOAN BIOTECH.H 1 across 1 annual periods. Explore SHANDONG BOAN BIOTECH.H 1 (UJ9) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

SHANDONG BOAN BIOTECH.H 1 Cash Flow Reinvestment Rate by Year (2025–2025)

SHANDONG BOAN BIOTECH.H 1 cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for SHANDONG BOAN BIOTECH.H 1. For the full cash flow conversion analysis, see how efficiently does SHANDONG BOAN BIOTECH.H 1 generate cash.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 4.22x €274.05 Million €64.89 Million €274.05 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow